Vaxcyte, Inc.
PCVX
$54.58
-$1.63-2.90%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.69% | 1.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.16% | 7.14% | |||
| Operating Income | -13.16% | -7.14% | |||
| Income Before Tax | -15.82% | -27.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15.82% | -27.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.82% | -27.77% | |||
| EBIT | -13.16% | -7.14% | |||
| EBITDA | -11.48% | -7.15% | |||
| EPS Basic | -15.62% | -27.62% | |||
| Normalized Basic EPS | -15.62% | -27.62% | |||
| EPS Diluted | -15.62% | -27.62% | |||
| Normalized Diluted EPS | -15.62% | -27.62% | |||
| Average Basic Shares Outstanding | 0.17% | 0.12% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||